The Effect of Cold Application on Nausea and Vomiting in the Early Postoperative Period
1 other identifier
interventional
60
1 country
1
Brief Summary
As a result of the literature review, it has been seen that it has not yet been clarified whether cold application methods are effective on postoperative nausea and vomiting, and academic studies on this subject are needed. The aim of the planned study was to conduct a randomized controlled experimental study to evaluate the effect of the cold application method on nausea and vomiting and the need for antiemetic drugs in the early postoperative period. The research hypotheses are as follows: H1:Cold application method reduces nausea and vomiting in the early postoperative period. H1:The cold application method reduces the need for antiemetic drugs in the early postoperative period. H1:Cold application method in the early postoperative period increases patient satisfaction. Condition or disease: Postoperative nausea and vomiting,Postoperative antiemetic use status,Patient satisfaction,Effects of cold application method Intervention/treatment: There is an intervention group in which the cold application method is applied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 3, 2023
CompletedFirst Posted
Study publicly available on registry
June 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedJune 5, 2023
May 1, 2023
10 months
May 3, 2023
May 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Determining the mean scores of the experimental and control groups from the nausea numerical scale
Nausea Numerical Scale There are numbers from 0 to 10 on the scale.The scale is explained to the patients and asked to choose the number between 0 and 10 that best reflects their nausea. Zero usually indicates 'no nausea' while 10 represents 'unbearable nausea'. Evaluation will be made in the recovery room after the surgery, then at the 2nd and 6th hours.
two year
Determination of patient satisfaction of the experimental and control groups
The patient satisfaction scale is used to evaluate patient satisfaction.It consists of numbers between "0" and "10" to determine the satisfaction level of the patients after the A value of zero indicates "no satisfaction" with the practice, while a value of ten indicates "a lot of satisfaction". Satisfaction scale will be evaluated at the 6th hour after the surgery.
two year
Antiemetic use status of the groups
The patients' use of antiemetics after surgery will be questioned.
two year
Study Arms (2)
cold application group
EXPERIMENTALA cold application (with a cold gel pack) will be applied to the upper part of the neck for 5 minutes.
standard treatment
NO INTERVENTIONNo application will be made and the presence of nausea, severity, vomiting and vital signs will be measured after 5 minutes.
Interventions
A cold application (with a cold gel pack) will be applied to the upper part of the neck for 5 minutes.
Eligibility Criteria
You may qualify if:
- Those who will undergo elective surgery
- Attempting laparoscopic cholecystectomy
- Those between the ages of 18-65
- Those who will receive general anesthesia
- Not allergic to cold
- Body temperature ≥36°C
- ASA I and ASA II class
- Those with an Apfel risk score of 2 and above
- Postoperative nausea severity of 2 and above
- Without chronic disease
- Neurological problems
- No problem communicating,• No hearing and vision problems
- Being conscious, awake and oriented after surgery,
- Patients who volunteer to participate in the study will be included in the study
You may not qualify if:
- Those who are allergic to cold
- Body temperature \<36°C,
- Those who have a disability, incision and surgical procedure around the head and neck
- Having chronic illness
- Having neurological problems
- Having nasogastric tube
- Postoperatively conscious, awake and not oriented,
- Patients who do not volunteer to participate in the study will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zonguldak Bulent Ecevit University
Zonguldak, Kozlu, 67100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nigar AK TURKİS, PhD student
Zonguldak Bulent Ecevit University,PhD student
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctoral Candidate in Surgical Nursing Science
Study Record Dates
First Submitted
May 3, 2023
First Posted
June 5, 2023
Study Start
October 1, 2022
Primary Completion
July 30, 2023
Study Completion
October 30, 2024
Last Updated
June 5, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share